In continuation to disclosure dated March 8, 2019 regarding participation of the Company's senior management in Valorem Analyst Conference 2019, organized by Valorem Advisors on March 13, 2019, Camlin Fine Sciences has informed that all discussions were based around general business updates and did not involve any forward looking statements or unpublished price sensitive information.
The above information is a part of company’s filings submitted to BSE.